Latest News and Press Releases
Want to stay updated on the latest news?
-
BELLEVUE, Wash., Dec. 07, 2022 (GLOBE NEWSWIRE) -- BodiGuide Inc. today announced a new technology capable of continuously measuring leg edema and quantifying fluid retention has been developed by...
-
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Hereditary Angioedema Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering....
-
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "Sodium Hyaluronate-based Products Market Share, Size, Trends, Industry Analysis Report, By Type; By Application; By Region; Segment Forecast, 2022 -...
-
Dublin, March 01, 2022 (GLOBE NEWSWIRE) -- The "Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Condition Type, Treatment Type, and End-User" report has been...
-
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
-
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
-
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
-
LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...